Skip to main content
Erschienen in: Head and Neck Pathology 1/2013

01.07.2013 | Invited Review: An Update on Salivary Gland Pathology

Carcinoma Ex Pleomorphic Adenoma, with Particular Emphasis on Early Lesions

verfasst von: Silvana Di Palma

Erschienen in: Head and Neck Pathology | Sonderheft 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Carcinoma ex pleomorphic adenoma (CXPA) is a broad category of carcinomas of the salivary glands which includes at least 2 clinically relevant categories; one is referred here as early CXPA (ECXPA), the other as widely invasive CXPA. The former includes several histological patterns ranging from non-invasive/in situ/intraductal/intratubular, early invasive/extratubular/intracapsular and extracapsular (up to 6 mm). The latter includes any CXPA with invasion of >6 mm. The clinical behaviour of ECXPA is not aggressive and tends to overlap that of a pleomorphic adenoma (PA) which makes the histological report of carcinoma contradictory. These early malignant changes in PA are known since the 1970s but it has been the use of immunohistochemical and molecular genetic analysis for HER-2 and TP53 gene in the last decade that has clarified the genuine malignant nature of the cells. HER-2 and TP53 gene and protein are involved in the early stages of malignant transformation of PA. Moreover the immunohistochemical over-expression HER-2, p53 protein and Mib-1 proliferation marker may be useful markers to identify malignant areas in PA.
Literatur
1.
Zurück zum Zitat Gnepp DR, Brandwein-Gensler MS, El-Naggar AK, Nagao T. Carcinoma ex pleomorphic adenoma. In: Barnes EL, Everson JW, El-Naggar AK, editors.WHO classification of tumors, vol. 9. 2005. p.242–3. Gnepp DR, Brandwein-Gensler MS, El-Naggar AK, Nagao T. Carcinoma ex pleomorphic adenoma. In: Barnes EL, Everson JW, El-Naggar AK, editors.WHO classification of tumors, vol. 9. 2005. p.242–3.
2.
Zurück zum Zitat Auclair PL, Ellis GL. Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. Mod Pathol. 1996;9:652–7.PubMed Auclair PL, Ellis GL. Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. Mod Pathol. 1996;9:652–7.PubMed
3.
Zurück zum Zitat Skálová A, Altemani A, Di Palma S, Simpson R, Hostička L, Andrle P, Laco J, Toner M, Vozmitsel M, Szakacs S, Kazakov D, Kinkor Z, Michal M. Pleomorphic adenoma of the salivary glands with intravascular tumor deposits, A diagnostic pitfall. Am J Surg Pathol. 2012;36:1674–82.PubMedCrossRef Skálová A, Altemani A, Di Palma S, Simpson R, Hostička L, Andrle P, Laco J, Toner M, Vozmitsel M, Szakacs S, Kazakov D, Kinkor Z, Michal M. Pleomorphic adenoma of the salivary glands with intravascular tumor deposits, A diagnostic pitfall. Am J Surg Pathol. 2012;36:1674–82.PubMedCrossRef
4.
Zurück zum Zitat Di Palma S, Skálová A, Vanìèek T, Simpson RH, Stárek I, Leivo I. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER2/neu and MIB1 immunohistochemistry. Histopathology. 2005;46:144–52.PubMedCrossRef Di Palma S, Skálová A, Vanìèek T, Simpson RH, Stárek I, Leivo I. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER2/neu and MIB1 immunohistochemistry. Histopathology. 2005;46:144–52.PubMedCrossRef
5.
Zurück zum Zitat Wenig BM, Hitchcock CL, Ellis GL, Gnepp DR. Metastasizing mixed tumour of salivary glands: a clinicopathologic and flow cytometric analysis. Am J Surg Pathol. 1992;16:845–58.PubMedCrossRef Wenig BM, Hitchcock CL, Ellis GL, Gnepp DR. Metastasizing mixed tumour of salivary glands: a clinicopathologic and flow cytometric analysis. Am J Surg Pathol. 1992;16:845–58.PubMedCrossRef
6.
Zurück zum Zitat LiVolsi VA, Perzin KH. Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer. 1977;39(5):2209–30.PubMedCrossRef LiVolsi VA, Perzin KH. Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer. 1977;39(5):2209–30.PubMedCrossRef
7.
Zurück zum Zitat Nagao K, Matsuzaki O, Saiga H, Sugano I, Shigematsu H, Kaneko T, Katoh T, Kitamura T. Histopathologic studies on carcinoma in pleomorphic adenoma of the parotid gland. Cancer. 1981;48:113–21.PubMedCrossRef Nagao K, Matsuzaki O, Saiga H, Sugano I, Shigematsu H, Kaneko T, Katoh T, Kitamura T. Histopathologic studies on carcinoma in pleomorphic adenoma of the parotid gland. Cancer. 1981;48:113–21.PubMedCrossRef
8.
Zurück zum Zitat Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu. 1993;28(1):279–328.PubMed Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu. 1993;28(1):279–328.PubMed
9.
Zurück zum Zitat Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol. 2001;32:596–604.PubMedCrossRef Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol. 2001;32:596–604.PubMedCrossRef
10.
Zurück zum Zitat Brandwein M, Huvos AG, Dardick I, Thomas MJ, Theise ND. Non-invasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:655–64.PubMedCrossRef Brandwein M, Huvos AG, Dardick I, Thomas MJ, Theise ND. Non-invasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:655–64.PubMedCrossRef
11.
Zurück zum Zitat Waldron CA, el Mofty SK, Gnepp DR. Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases. Oral Surg Oral Med Oral Pathol. 1988;66:323–33.PubMedCrossRef Waldron CA, el Mofty SK, Gnepp DR. Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases. Oral Surg Oral Med Oral Pathol. 1988;66:323–33.PubMedCrossRef
12.
Zurück zum Zitat Di Palma S. Malignancy in pleomorphic adenoma (malignant mixed tumour) of salivary glands. In: Gale N, Luzar B editors. Proceedings in head and neck pathology. Institute of Pathology Faculty of Medicine, University of Lubljana, Lubljana 4–6 September 2003, pp 92–8. Di Palma S. Malignancy in pleomorphic adenoma (malignant mixed tumour) of salivary glands. In: Gale N, Luzar B editors. Proceedings in head and neck pathology. Institute of Pathology Faculty of Medicine, University of Lubljana, Lubljana 4–6 September 2003, pp 92–8.
13.
Zurück zum Zitat Ellis GL, Auclair RL (2008) Tumours of the salivary glands. Washington, DC: Armed Forces Institute of Pathology 9:259–69. Ellis GL, Auclair RL (2008) Tumours of the salivary glands. Washington, DC: Armed Forces Institute of Pathology 9:259–69.
14.
Zurück zum Zitat Ihrler S, Weiler C, Hirschmann A, et al. Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53. Histopathology. 2007;51:362–71.PubMedCrossRef Ihrler S, Weiler C, Hirschmann A, et al. Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53. Histopathology. 2007;51:362–71.PubMedCrossRef
15.
Zurück zum Zitat Brandwein-Gensler MS, Skalova A, Nagao T. Salivary duct carcinoma. WHO classification of tumours. In: Barnes EL, Eveson JW, El-Naggar 2005;9:236–37. Brandwein-Gensler MS, Skalova A, Nagao T. Salivary duct carcinoma. WHO classification of tumours. In: Barnes EL, Eveson JW, El-Naggar 2005;9:236–37.
16.
Zurück zum Zitat Spiro RH, Huvos AG, Strong EW. Malignant mixed tumor of salivary origin: a clinicopathologic study of 146 cases. Cancer. 1977;39:388–96.PubMedCrossRef Spiro RH, Huvos AG, Strong EW. Malignant mixed tumor of salivary origin: a clinicopathologic study of 146 cases. Cancer. 1977;39:388–96.PubMedCrossRef
17.
Zurück zum Zitat Di Palma S, Pilotti S, Rilke F. Malignant myoepithelioma of the parotid arising in a pleomorphic adenoma. Histopathology. 1991;19:273–5.PubMedCrossRef Di Palma S, Pilotti S, Rilke F. Malignant myoepithelioma of the parotid arising in a pleomorphic adenoma. Histopathology. 1991;19:273–5.PubMedCrossRef
18.
Zurück zum Zitat Alos LL, Cardesa A, Bombi JA, Mallofre C, Cuchi A, Traserra J. Myoepithelial tumors of salivary glands: a clinicopathologic, immunohistochemical and flow-cytometric study. Semin Diagn Pathol. 1996;13:138–47.PubMed Alos LL, Cardesa A, Bombi JA, Mallofre C, Cuchi A, Traserra J. Myoepithelial tumors of salivary glands: a clinicopathologic, immunohistochemical and flow-cytometric study. Semin Diagn Pathol. 1996;13:138–47.PubMed
19.
Zurück zum Zitat Savera AT, Sloman A, Huvos AG, Klimstra DS. Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients. Am J Surg Pathol. 2000;24:761–74.PubMedCrossRef Savera AT, Sloman A, Huvos AG, Klimstra DS. Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients. Am J Surg Pathol. 2000;24:761–74.PubMedCrossRef
20.
Zurück zum Zitat Weiler C, Zengel P, van der Wal JE, Guntinas-Lichius O, Schwarz S, Harrison JD, Kirchner T, Ihrler S, et al. Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases. Histopathology. 2011;59:741–50.PubMedCrossRef Weiler C, Zengel P, van der Wal JE, Guntinas-Lichius O, Schwarz S, Harrison JD, Kirchner T, Ihrler S, et al. Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases. Histopathology. 2011;59:741–50.PubMedCrossRef
21.
Zurück zum Zitat Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck. 2001;23:705–12.PubMedCrossRef Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck. 2001;23:705–12.PubMedCrossRef
22.
Zurück zum Zitat Tortoledo ME, Luna MA, Batsakis JG. Carcinomas ex pleomorphic adenoma and malignant mixed tumours. Histomorphologic indexes. Arch Otolaryngol. 1984;110:172–6.PubMedCrossRef Tortoledo ME, Luna MA, Batsakis JG. Carcinomas ex pleomorphic adenoma and malignant mixed tumours. Histomorphologic indexes. Arch Otolaryngol. 1984;110:172–6.PubMedCrossRef
23.
Zurück zum Zitat Katabi N, Gomez D, Klimstra DS, Carlson DL, Lee N, Ghossein R. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopatholgic study of 43 cases. Hum Pathol. 2010;41:927–34.PubMedCrossRef Katabi N, Gomez D, Klimstra DS, Carlson DL, Lee N, Ghossein R. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopatholgic study of 43 cases. Hum Pathol. 2010;41:927–34.PubMedCrossRef
24.
Zurück zum Zitat Hashimoto K, Yamamoto H, Shiratsuchi H, et al. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in situ hybridization study. Histopathology. 2012;60:E131–42.PubMedCrossRef Hashimoto K, Yamamoto H, Shiratsuchi H, et al. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in situ hybridization study. Histopathology. 2012;60:E131–42.PubMedCrossRef
25.
Zurück zum Zitat Skálová A, Stárek I, Vanecek T, Kucerová V, Plank L, Szépe P, Di Palma S, Leivo I. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in situ hybridization and immunohistochemistry. Histopathology. 2003;42(4):348–56.PubMedCrossRef Skálová A, Stárek I, Vanecek T, Kucerová V, Plank L, Szépe P, Di Palma S, Leivo I. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in situ hybridization and immunohistochemistry. Histopathology. 2003;42(4):348–56.PubMedCrossRef
26.
Zurück zum Zitat Simpson RH, Desai S, Di Palma S. Salivary duct carcinoma in situ of the parotid gland. Histopathology. 2008;53:416–25.PubMedCrossRef Simpson RH, Desai S, Di Palma S. Salivary duct carcinoma in situ of the parotid gland. Histopathology. 2008;53:416–25.PubMedCrossRef
27.
Zurück zum Zitat Di Palma S, Simpson R, Marchio C, Skalova A, Ungari M, Sandison A, Whitaker S, Parry S, Reis-Filho J. Pure salivary duct carcinomas can be classified into luminal, HER2 and basal-like phenotypes. Histopathology. 2012;61:629–43.PubMed Di Palma S, Simpson R, Marchio C, Skalova A, Ungari M, Sandison A, Whitaker S, Parry S, Reis-Filho J. Pure salivary duct carcinomas can be classified into luminal, HER2 and basal-like phenotypes. Histopathology. 2012;61:629–43.PubMed
28.
Zurück zum Zitat Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989;244:707–12.PubMedCrossRef Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989;244:707–12.PubMedCrossRef
29.
Zurück zum Zitat Sharon E, Kelly RJ, Szabo E. Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine. Head Neck Oncol. 2010;26:2–12. Sharon E, Kelly RJ, Szabo E. Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine. Head Neck Oncol. 2010;26:2–12.
30.
Zurück zum Zitat Di Palma S, Whitaker S, Potter K, Pitkin L. Carcinoma ex pleomorphic adenoma successfully treated with trastuzumab and radiotherapy. Poster 021 presented at the 24th European congress of pathology. Prague. 2012. 8–12 September, 2012. Di Palma S, Whitaker S, Potter K, Pitkin L. Carcinoma ex pleomorphic adenoma successfully treated with trastuzumab and radiotherapy. Poster 021 presented at the 24th European congress of pathology. Prague. 2012. 8–12 September, 2012.
31.
Zurück zum Zitat De Roche TC, Hoschar AP, Hunt JL. Immunohistochemical evaluation of androgen receptor, HER2/neu, and p53 in benign pleomorphic adenomas. Arch Pathol Lab Med. 2008;132(12):1907–11. De Roche TC, Hoschar AP, Hunt JL. Immunohistochemical evaluation of androgen receptor, HER2/neu, and p53 in benign pleomorphic adenomas. Arch Pathol Lab Med. 2008;132(12):1907–11.
32.
Zurück zum Zitat Altemani A, Martins MT, Freitas L, Soares F, Araujo NS, Araujo VC. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology. 2005;46:635–41.PubMedCrossRef Altemani A, Martins MT, Freitas L, Soares F, Araujo NS, Araujo VC. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology. 2005;46:635–41.PubMedCrossRef
Metadaten
Titel
Carcinoma Ex Pleomorphic Adenoma, with Particular Emphasis on Early Lesions
verfasst von
Silvana Di Palma
Publikationsdatum
01.07.2013
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe Sonderheft 1/2013
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-013-0454-z

Weitere Artikel der Sonderheft 1/2013

Head and Neck Pathology 1/2013 Zur Ausgabe

Invited Review: An Update on Salivary Gland Pathology

An Update on Salivary Gland Pathology

Invited Review: An Update on Salivary Gland Pathology

Hyalinizing Clear Cell Carcinoma of Salivary Gland: A Review and Update

Neu im Fachgebiet Pathologie